The immune-endocrine-metabolic unit during human tuberculosis

Current Immunology Reviews

Volumn 6, Issue 4, 2010, Pages 314-322

  Bottasso, Oscar ^a   Bay, María Luisa ^b   Besedovsky, Hugo ^b   del Rey, Adriana ^b  

^a FACULTAD DE CIENCIAS MÉDICAS   (Argentina)

^b PHILIPPS UNIVERSITY MARBURG   (Germany)

Author keywords

Adaptive immunity; Metabolism; Neuroendocrine regulation; Tuberculosis; Weight loss

Indexed keywords

ADIPOCYTOKINE; CORTICOSTEROID; CYTOKINE; ESTRADIOL; GAMMA INTERFERON; GROWTH HORMONE; HYDROCORTISONE; INTERLEUKIN 10; INTERLEUKIN 6; LEPTIN; LIOTHYRONINE; PRASTERONE; PROLACTIN; SOMATOMEDIN C; TESTOSTERONE; THYROID HORMONE; THYROXINE;

ADAPTIVE IMMUNITY; ARTICLE; BACTERIUM CULTURE; CELLULAR IMMUNITY; DISEASE ASSOCIATION; ENDOCRINE FUNCTION; HOST RESISTANCE; HUMAN; IMMUNE RESPONSE; IMMUNITY; IMMUNOMODULATION; IMMUNOREGULATION; IN VITRO STUDY; INFECTION; INNATE IMMUNITY; METABOLISM; MYCOBACTERIUM TUBERCULOSIS; NEUROENDOCRINE SYSTEM; NONHUMAN; PERIPHERAL BLOOD MONONUCLEAR CELL; PLEIOTROPY; PRIORITY JOURNAL; REGULATORY T LYMPHOCYTE; STEROID RELEASE; SUPERNATANT; TISSUE INJURY; TUBERCULOSIS; WEIGHT REDUCTION;

EID: 78649305415     PISSN: 15733955     EISSN: None     Source Type: Journal    
DOI: 10.2174/1573395511006040314     Document Type: Article

References (106)

1. Baumann H, Gauldie J. The acute phase response. Immunol Today1994; 15: 74-80.
2. Hart BL. Behavioral adaptations to pathogens and parasites: fivestrategies. Neurosci Biobehav Rev 1990; 14: 273-94.
3. Weinberg ED. Iron withholding: a defense against infection andneoplasia. Physiol Rev 1984; 64:65-102.
4. Bonneaud C, Mauc J, Gonzalez G, et al. Assessing the cost ofmounting an immune response. Am Nat 203; 161: 367-9
5. Hotamisligil G, Erbay E. Nutrient sensing and inflammation inmetabolic diseases. Nature Rev Immunol 2008; 18(12): 923-34.
6. Norgan NG. The beneficial effects of body fat and adipose tissue inhumans. Int J Obes Relat Metab Disord 1997; 21: 738-46.
7. Spurlock ME, Frank GR, Willis GM, Kuske JL, Cornelius SG.Effect of dietary energy source and immunological challenge ongrowth performance and immunological variables in growing pigs.Anim Sci 1997; 75: 720-6.
8. Trayhurn P, Wood S. Adipokines: inflammation and the pleiotropicrole in white adipose tissue. Br J Nutr 2004; 92: 347-55.
9. Martin-Romero C, Santos-Alvarez J, Goberna R, Sanchez-Margalet V. Human leptin enhances activation and proliferation of humancirculating T lymphocytes. Cell Immunol 2000; 199: 15-24
10. Farooqi IS, Matarese G, Lord GM, et al. Beneficial effects of leptinon obesity, T cell hyporesponsiveness, and neuroendocrine/meta-bolic dysfunction of human congenital leptin deficiency. J ClinInvest 2002; 110: 1093-103.
11. Raso GM, Pacilio M, Esposito E, Coppola A, Di Carlo R, Meli R.Leptin potentiates IFN-gamma-induced expression of nitric oxidesynthase and cyclo-oxygenase-2 in murine macrophage J774A. 1.Br J Pharmacol 2002; 137: 799-804.
12. La Cava A, G Matarese. The weight of leptin in immunity. Nat RevImmunol 2004; 4: 371-9.
13. Matarese G, Moschos S, Mantzoros CS. Leptin in immunology. JImmunol 2005; 174: 3137-42.
14. Halaas JL, Gajiwala KS, Maffei M, et al. Weight-reducing effectsof the plasma protein encoded by the obese gene. Science 1995;269: 543-6.
15. Chan JL, Heist K, DePaoli AM, Veldhuis JD, Mantzoros CS. Therole of falling leptin levels in the neuroendocrine and metabolicadaptation to short-term starvation in healthy men. J Clin Invest2003; 111:1409-21.
16. Considine RV, Sinha MK, Heiman ML, et al. Serum immunoreactive-leptin concentrations in normal-weight and obesehumans. N Engl J Med 1996; 334: 292-5
17. Tartaglia LA, Dembski M, Weng X, et al. Identification andexpression cloning of a leptin receptor, OB-R. Cell 1995; 83: 1263-71.
18. Lee GH, Proenca R, Montez JM, et al. Abnormal splicing of theleptin receptor in diabetic mice. Nature 1996; 379: 632-5.
19. Otero M, Lago R, Lago F, et al. Leptin, from fat to inflammation:old questions and new insights. FEBS Lett 2005; 579: 295-301.
20. Boden G, Chen X, Kolaczynski JW, Polansky M. Effects ofprolonged hyperinsulinemia on serum leptin in normal humansubjects. J Clin Invest 1997; 100: 1107-13.
21. Zakrzewska KE, Cusin I, Sainsbury A, Rohner-Jeanrenaud F,Jeanrenaud B. Glucocorticoids as counterregulatory hormones ofleptin: toward an understanding of leptin resistance. Diabetes 1997;46: 717-9.
22. Kruse M, Bornstein SR, Uhlmann K, Paeth G, Scherbaum WA.Leptin down-regulates the steroid producing system in the adrenal.Endocr Res 1998; 24: 587-90.
23. Sarraf P, Frederich RC, Turner EM, et al. Multiple cytokines andacute inflammation raise mouse leptin levels: potential role ininflammatory anorexia. J Exp Med 1997; 185: 171-5.
24. Popa C, Netea MG, Radstake TR, van Riel PL, Barrera P, van der Meer JW. Markers of inflammation are negatively correlated withserum leptin in rheumatoid arthritis. Ann Rheum Dis 2005; 64:1195-8.
25. Zhang HH, Kumar S, Barnett AH, Eggo MC. Tumour necrosisfactor-alpha exerts dual effects on human adipose leptin synthesisand release. Mol Cell Endocrinol 2000; 159: 79-88.
26. Luheshi GN, Gardner JD, Rushforth DA, Loudon AS, Rothwell NJ.Leptin actions on food intake and body temperature are mediatedby IL-1. Proc Natl Acad Sci USA 1999; 96: 7047-52.
27. Del Rey A, Roggero E, Randolf A, et al. IL-1 resets glucosehomeostasis at central levels. Proc Natl Acad Sci USA 2006 24;103: 16039-44.
28. Scherer PE, Williams S, Fogliano M, Baldini G, Lodish HF. Anovel serum protein similar to C1q, produced exclusively inadipocytes. J Biol Chem 1995; 270: 26746-9.
29. Shapiro L, Scherer PE. The crystal structure of a complement-1qfamily protein suggests an evolutionary link to tumor necrosisfactor. Curr Biol 1998; 8: 335-8.
30. Wulster-Radcliffe MC, Ajuwon KM, Wang J, Christian JA, Spurlock ME. Adiponectin differentially regulates cytokines inporcine macrophages. Biochem Biophys Res Commun 2004; 316:924-9.
31. Wolf AM, Wolf D, Rumpold H, Enrich B, Tilg H. Adiponectininduces the anti-inflammatory cytokines IL-10 and IL-1RA inhuman leukocytes. Biochem Biophys Res Commun 2004; 323:630-5.
32. Engeli S, Feldpausch M, Gorzelniak K, et al. Association betweenadiponectin and mediators of inflammation in obese women.Diabetes 2003; 52: 942-7.
33. Tsao TS, Murrey HE, Hug C, Lee DH, Lodish HF. Oligomerizationstate-dependent activation of NF-B signaling pathway byadipocyte complement-related protein of 30 kDa (Acrp30). J BiolChem 2002; 277: 29359 -62.
34. Beltowski J. Adiponectin and resistin-new hormones of whiteadipose tissue. Med Sci Monit 2003; 9: RA55-61.
35. Mohamed-Ali V, Flower L, Sethi J, et al. Beta-Adrenergicregulation of IL-6 release from adipose tissue: in vivo and in vitrostudies. J Clin Endocrinol Metab 2001; 86: 5864-9.
36. Maffei M, Halaas J, Ravussin E, et al. Leptin levels in human androdent: measurement of plasma leptin and ob RNA in obese andweight-reduced subjects. Nat Med 1995; 1: 1155-61.
37. Kappes A, Loffler G. Influences of ionomycin, dibutyryl-cycloAMP and tumor necrosis factor alpha on intracellular amountand secretion of apM1 in differentiating primary humanpreadipocytes. Hormone Metab Res 2000; 32: 548-54.
38. Masaki T, Chiba S, Tatsukawa H, et al. Adiponectin protects LPS-induced liver injury through modulation of TNF-alpha in KK-Ayobese mice. Hepatology 2004; 40: 177-84.
39. Kumada M, Kihara S, Ouchi N, et al. Adiponectin specificallyincreased tissue inhibitor of metalloprotenase-1 throughinterleukin-10 expression in human macrophages. Circulation2004; 109: 2046-9.
40. Neary NM, Goldstone AP, Bloom SR. Appetite regulation: fromthe gut to the hypothalamus. Clin Endocrinol 2004; 60: 153-60.
41. Cummings DE, Foster-Schubert KE, Overduin J. Ghrelin andenergy balance: focus on current controversies. Curr Drug Targets2005; 6: 153-169.
42. Wortley KE, del Rincon JP, Murray JD, et al. Absence of ghrelinprotects against early-onset obesity. J Clin Invest 2005; 115: 3573-8.
43. Zigman JM, Nakano Y, Coppari R. et al. Mice lacking ghrelinreceptors resist the development of diet-induced obesity. J ClinInvest 2005; 115: 3564-72.
44. Ota K, Wildmann J, Ota T, Besedovsky H, del Rey A. IL-1b andinsulin elicit different neuro-endocrine responses to hypoglycemia.Ann NY Acad Sci 2009; 1153:82-8.
45. Langhans W. Anorexia of infection: current prospects. Nutrition2000; 16: 996-1005.
46. Rothwell NJ, Busbridge NJ, Lefeuvre RA, Hardwick AJ, Gauldie J, Hopkins SJ. Interleukin-6 is a centrally acting endogenous pyrogenin the rat. Can J Physiol Pharmacol 1991; 69: 1465-9.
47. Wallenius V, Wallenius K, Ahren B, et al. Interleukin-6-deficientmice develop mature-onset obesity. Nat Med 2002: 8: 75-9.
48. Stenlof K, Wernstedt I, Fjallman T, Wallenius V, Wallenius K, Jansson JO. Interleukin-6 levels in the central nervous system arenegatively correlated with fat mass in overweight/obese subjects. JClin Endocrinol Metab 2003; 88: 4379-83.
49. Phillips RS, Enwonwu CO, Okolo S, Hassan A. Metabolic effectsof acute measles in chronically malnourished Nigerian children. JNutr Biochem 2004; 15: 281-8.
50. Woodward B. Protein, calories, and immune defenses. Nutr Rev1998; 56: S84-S92.
51. Jacobson L. Hypothalamic-pituitaryadrenocortical axis regulation.Endocrinol Metab Clin North Am 2005; 34: 271-92.
52. Miyaura H, Iwata M. Direct and indirect inhibition of Th1development by progesterone and glucocorticoids. J Immunol2002; 168: 1087-94.
53. WHO. Global tuberculosis control - surveillance, planning,financing. WHO/HTM/TB 2008. 393. Geneva: World HealthOrganization, 2008.
54. Flynn JL. Immunology of tuberculosis and implications in vaccinedevelopment. Tuberculosis 2004; 84: 93-101.
55. Dannenberg AM Jr., Rook GA. Pathogenesis of pulmonarytuberculosis: an interplay between tissue-damaging andmacrophage-activating immune responses: dual mechanisms thatcontrol bacillary multiplication. In: Bloom BR Ed, Tuberculosis:pathogenesis, protection, and control, ASM Press, Washington, DC1994; 459-84.
56. Boom WH. The role of T-cell subsets in Mycobacteriumtuberculosis infection. Infect Agents Dis 1996; 5: 73-81.
57. Cooper AM, Adams LB, Dalton DK, Appelberg R, Ehlers S. IFN-gamma and NO in mycobacterial disease: new jobs for old hands.Trend Microbiol 2002; 10: 221-6.
58. Hernandez Pando R, Orozco H, Sampieri A, et al. Correlationbetween the kinetics of Th1/Th2 cells and pathology in a murinemodel of experimental pulmonary tuberculosis. Immunology 1996;89: 26-33.
59. Howard AD, Zwilling BS. Reactivation of tuberculosis isassociated with a shift from type 1 to type 2 cytokines. Clin ExpImmunol 1999; 115: 428-34.
60. North RJ. Mice incapable of making IL-4 or IL-10 display normalresistance to infection with Mycobacterium tuberculosis. Clin ExpImmunol 1998; 113: 55-8.
61. Erb KJ, Kirman J, Delahunt B, Chen W, Le Gros G. IL-4, IL-5 andIL-10 are not required for the control of M. bovis-BCG infection inmice. Immunol Cell Biol 1998; 76: 41-6.
62. Sanchez FO, Rodriguez JI, Garcia LF. Immune responsiveness andlymphokine production in patients with tuberculosis and healthycontrols. Infect Immun 1994; 62: 5673-8.
63. Schauf V, Rom WN, Smith KA, et al. Cytokine gene activation andmodified responsiveness to interleukin-2 in the blood oftuberculosis patients. J Infect Dis 1993; 168: 1056-9.
64. Surcel HM, Troye-Blomberg M, Paulie S, et al. Th1/Th2 profiles intuberculosis, based on the proliferation and cytokine response ofblood lymphocytes to mycobacterial antigens. Immunology 1994;81:171-6.
65. van Crevel R, Karyadi E, Preyers F, et al. Increased production ofinterleukin 4 by CD4+ and CD8+ T cells from patients withtuberculosis is related to the presence of pulmonary cavities. JInfect Dis 2000; 181: 1194-7.
66. Lai CK, Ho S, Chan CH, et al. Cytokine gene expression profile ofcirculating CD4+ T cells in active pulmonary tuberculosis. Chest1997; 111: 606-11.
67. Lin Y, Zhang M, Hofman FM, Gong J, Barnes PF. Absence of aprominent Th2 cytokine response in human tuberculosis. InfectImmun 1996; 64: 1351-6.
68. Dlugovitzky D, Bay ML, Rateni L, et al. Influence of diseaseseverity on nitrite and cytokine production by peripheral bloodmononuclear cells from patients with pulmonary tuberculosis. ClinExp Immunol 2000; 122: 343-9.
69. Bottasso O, Bay ML, Besedovsky H, del Rey A. The immuno-endocrine component in the pathogenesis of tuberculosis. Scand JImmunol 2007; 66: 166-75.
70. Mahuad C, Bay ML, Farroni MA, et al. Cortisol and dehydroepiandrosterone affect the response of peripheral bloodmononuclear cells to mycobacterial antigens during tuberculosis.Scand J Immunol 2004; 60: 639-46.
71. del Rey A, Mahuad CV, Bozza V, et al. Endocrine and cytokineresponses in humans with pulmonary tuberculosis. Brain BehavImmun 2007; 21: 171-9.
72. Van den Berghe G. Endocrine evaluation of patients with criticalillness. Endocrinol Metab Clin North Am 2003; 32: 385-410.
73. Besedovsky H, del Rey A. Immune-neuro-endocrine interactions:Facts and Hypothesis. Endocr Rev 1996; 17: 64-95.
74. Turnbull AV, Rivier CL. Regulation of the hypothalamic-pituitary-adrenal axis by cytokines: actions and mechanisms of action.Physiological Rev 1999; 79: 1-71.
75. Straub RH, Pongratz G, Schölmerich J, et al. Long-term anti-tumornecrosis factor antibody therapy in rheumatoid arthritis patientssensitizes the pituitary gland and favors adrenal androgen secretion.Arthritis Rheum 2003; 48: 1504-12.
76. Elenkov IJ, Chrousos GP. Stress hormones, Th1/Th2 patterns,pro/anti-inflammatory cytokines and susceptibility to disease.Trends Endocrinol Metab 1999; 10: 359-68.
77. Dillon J: Dehydroepiandrosterone, dehydroepiandrosterone sulfateand related steroids: their role in inflammatory, allergic andimmunological disorders. Current Drug Targets - Inflamm Allergy2005; 4: 377-85.
78. Bozza VV, D'Attilio L, Mahuad CV, et al. Altered Cortisol/DHEAratio in tuberculosis patients and its relationship with abnormalitiesin the mycobacterial-driven cytokine production by peripheralblood mononuclear cells. Scand J Immunol 2007; 66: 97-103.
79. Foster MP, Jensen ER, Montecino-Rodriguez E, Leathers H, Horseman N, Dorshkind K. Humoral and cell-mediated immunityin mice with genetic deficiencies of prolactin, growth hormone,insulin-like growth factor-I, and thyroid hormone. Clin Immunol2000; 96: 140-9.
80. Malkin J, Pugh PJ, Jones R D, Kapoor D, Channer KS, Jones TH.The effect of testosterone replacement on endogenousinflammatory cytokines and lipid profiles in hypogonadal men. JClin Endocrinol Metab 2004; 89: 3313-8.
81. Cutolo M, Capellino S, Montagna P, et al. New roles for estrogensin rheumatoid arthritis. Clin Exp Rheumatol 2003; 21: 687-90.
82. Dorshkind K, Horseman ND. The roles of prolactin, growthhormone, insulin-like growth factor-I, and thyroid hormones inlymphocyte development and function: insights from geneticmodels of hormone and hormone receptor deficiency. Endocr Rev2000; 21: 292-312.
83. Plata-Salaman CR. Cytokines and feeding. Int J Obesity 2001; 25:S48-S52.
84. Langhans W. Anorexia of infection: current prospects. Nutrition2000; 16: 996-1005.
85. Schwenk A, Macallan DC. Tuberculosis, malnutrition and wasting.Curr Opin Clin Nutr Metab Care 2000; 3: 285-91.
86. Palenicek J, Nelson KE, Vlahov D, Galai N, Cohn S, Saah AJ.Comparison of clinical symptoms of human immunodeficiencyvirus disease between intravenous drug users and homosexual men.Arch Intern Med 1993; 153: 1806-12.
87. Davies PDO, Yew WW, Ganguly D, et al. Smoking andtuberculosis: the epidemiological association andimmunopathogenesis. Trans R Soc Trop Med Hyg 2006; 100: 291-8.
88. Brown KE, Campbell AH. Tobacco, alcohol and tuberculosis. Br JDis Chest 1961; 55: 150-8.
89. Mahuad C, Bozza V, Pezzotto SM, et al. Impaired ImmuneResponses in tuberculosis patients are related to weight loss thatcoexists with an immunoendocrine imbalance. Neuroimmuno-modulation 2007; 14: 193-9.
90. van Lettow M, van der Meer JWM, West CE, van Crevel R, Semba RD. Interleukin-6 and human immunodeficiency virus load, nut notplasma leptin concentration, predict anorexia and wasting in adultswith pulmonary tuberculosis in Malawi. J Clin Endocrinol Metab2005; 90: 4771-6.
91. Dallman M, Strack A, Akana S, et al. Feast and famine: criticalrole of glucocorticoids with insulin in daily energy flow. FrontNeuroendocrinol 1993; 14:303-47.
92. Kellendonk C, Eiden S, Kretz O, et al. Inactivation of the GR in thenervous system affects energy accumulation. Endocrinology 2002;143: 2333-40.
93. Cakir B, Yonem A, Guler S, et al. Relation to leptin and tumornecrosis factor to body weight changes in patients withpulmonary tuberculosis. Horm Res 1999; 52: 279-83.
94. Yuksel I, Sencan M, Dokmetas HS, Dokmetas I, Ataseven H, Yonem A. The relation between serum leptin levels and body fatmass in patients with active lung tuberculosis. Endocr Res 2003;29: 257-64.
95. van Crevel R, Karyadi E, Netea MG, et al. Decreased plasma leptinconcentrations in tuberculosis patients are associated with wastingand inflammation. J Clin Endocrinol Metab 2002; 87: 758-63.
96. Schwenk A, Hodgson L, Rayner CFJ, Griffin GE, Macallan DC.Leptin and energy metabolism in pulmonary tuberculosis. Am JClin Nutr 2003; 77: 392-8.
97. Bozza V, D́Attilio L, Didoli, G, et al. The adrenal steroid responseduring tuberculosis and its effects on the mycobacterial-drivenIFN-production of patients and their household contacts. Ann NYAcad Sci 2009; 1153: 247-55.
98. Wieland CW, Florquin S, Chan ED, et al. Pulmonary Mycobacterium tuberculosis infection in leptin-deficient ob/obmice. Int Immunol 2005; 17: 1399-408.
99. Gracie JA, Robertson SE, McInnes IB. Interleukin-18. J LeukocBiol 2003; 73: 213-24.
100. Dlugovitzky D, Bay ML, Rateni L, et al. In vitro synthesis ofinterferon-, interleukin-4, transforming growth factor-, andinterleukin 1-by peripheral blood mononuclear cells fromtuberculosis patients. Relationship with the severity of pulmonaryinvolvement. Scand J Immunol 1999; 49: 210-7.
101. De Rosa V, Procaccini C, Calì G, et al. A Key Role of leptin in thecontrol of regulatory T cell proliferation. Immunity 2007; 26: 241-55.
102. Sakaguchi S, Yamaguchi T, Nomura T, Ono M. Regulatory T cellsand immune tolerance. Cell 2008; 133: 775-87.
103. Ribeiro-Rodrigues R, Resende CT, Rojas R, et al. A role forCD4+CD25+ T cells in regulation of the immune response duringhuman tuberculosis. Clin Exp Immunol 2006; 144: 25-34.
104. Guyot-Revol V, Innes JA, Hackforth S, Hinks T, Lalvani A.Regulatory T cells are expanded in blood and disease sites inpatients with tuberculosis. Am J Respir Crit Care Med 2006; 173:803-10.
105. Scott-Browne JP, Shafiani S, Tucker-Heard G, et al. Expansion andfunction of Foxp3-expressing T regulatory cells duringtuberculosis. J Exp Med 2007; 204: 2159-69.
106. low/- regulatory T cellsfrom peripheral blood lymphocytes of healthy Mycobacteriumtuberculosis-infected humans. Microbes Infect 2007; 9: 1325-32.